Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA Seeks Input On Inactive Ingredients Database
US Agency Plans To Prioritize Maximum Daily Exposure Information
Mar 30 2022
•
By
David Wallace
The FDA is seeking feedback on changes to its inactive ingredient database • Source: Thanee Hengpattanapong / Alamy Stock Vector
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics